Financial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing Treatment

This research trial studies the financial burden in patients with stage I-III colon or rectal cancer who are undergoing treatment. Collecting data from patients about their cost and quality of life may help doctors to better understand the impact of cancer treatment on a patient?s employment and finances.

Research Base: ECOG-ACRIN Cancer Research Group
NCT ID: NCT03516942
NCI Protocol Number: ECOG-ACRIN-EAQ162CD
Status: Recruiting

For more information see ClinicalTrials.gov

Interventions

Quality-of-Life Assessment; Questionnaire Administration

Condition

Stage I Colon Cancer AJCC v8, Stage I Rectal Cancer AJCC v8, Stage II Colon Cancer AJCC v8, Stage II Rectal Cancer AJCC v8, Stage IIA Colon Cancer AJCC v8, Stage IIA Rectal Cancer AJCC v8, Stage IIB Colon Cancer AJCC v8, Stage IIB Rectal Cancer AJCC v8, Stage IIC Colon Cancer AJCC v8, Stage IIC Rectal Cancer AJCC v8, Stage III Colon Cancer AJCC v8, Stage III Rectal Cancer AJCC v8, Stage IIIA Colon Cancer AJCC v8, Stage IIIA Rectal Cancer AJCC v8, Stage IIIB Colon Cancer AJCC v8, Stage IIIB Rectal Cancer AJCC v8, Stage IIIC Colon Cancer AJCC v8, Stage IIIC Rectal Cancer AJCC v8

Trial Type

Cancer Care Delivery Research (CCDR)

See a list of participating sites on ClinicalTrials.gov


˄
BACK TO
TOP